| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
1.9 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
MARK2 |
IPI00718858 |
1.9 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
CASP8 |
IPI00305242 |
1.9 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
STUB1 |
STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 |
1.9 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
1.9 |
Evidence |
|
| SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.9 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PHF3 |
PHF3, KIAA0244: PHD finger protein 3 |
1.9 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
1.9 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
1.9 |
Evidence |
|
| APC |
IPI00215877 |
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
1.9 |
Evidence |
|
| APC |
IPI00215877 |
CASP8 |
IPI00305242 |
1.9 |
Evidence |
|
| APC |
IPI00215877 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
1.9 |
Evidence |
|
| APC |
IPI00215877 |
BMX |
IPI00514142 |
1.9 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
1.9 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.9 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
1.9 |
Evidence |
|
| MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
GUCA2B |
GUCA2B: Guanylate cyclase activator 2B precursor [Contains: Guanylate cyclase C- |
1.9 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
MARK2 |
IPI00718858 |
1.9 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
1.9 |
Evidence |
|
| IL1RN |
IL1RN, IL1F3, IL1RA: Interleukin-1 receptor antagonist protein precursor |
MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
1.9 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
1.9 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GTF3C4 |
GTF3C4: General transcription factor 3C polypeptide 4 |
1.9 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
PTPNS1 |
IPI00332887 |
1.9 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
1.9 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
1.9 |
Evidence |
|